In previous studies, PPM1a down-regulation leads to a dramatic promotion on migration and invasiveness of bladder cancer, while inhibitors of TβRI (SB431542) treatment markedly abolished this effect [20]. This evidence concerns the gene TGFBR1 and urinary bladder carcinoma.